Gateway Investment Advisers’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-14,574
Closed -$779K 644
2014
Q4
$779K Sell
14,574
-83,682
-85% -$4.68M 0.01% 582
2014
Q3
$5.65M Buy
98,256
+3,657
+4% +$224K 0.04% 274
2014
Q2
$6.32M Sell
94,599
-39,744
-30% -$2.69M 0.05% 261
2014
Q1
$8.97M Sell
134,343
-13,818
-9% -$934K 0.07% 217
2013
Q4
$9.89M Sell
148,161
-3,329
-2% -$216K 0.08% 212
2013
Q3
$9.5M Buy
151,490
+31,400
+26% +$2.02M 0.08% 215
2013
Q2
$7.5M Buy
+120,090
New +$7.62M 0.07% 222

Other funds holding GSK

Gateway Investment Advisers's GSK Position: Q1 2015 in Review

Gateway Investment Advisers sold out of GSK (GSK) in Q1 2015, closing a stake of 14,574 shares — an estimated $779K sold.

Gateway Investment Advisers first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $9.89M in Q4 2013. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Gateway Investment Advisers reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • Gateway Investment Advisers sold 14,574 GSK shares in Q1 2015, an estimated $779K.
  • Gateway Investment Advisers first reported a position in GSK in Q2 2013 and held it in 7 quarters.
  • Gateway Investment Advisers's GSK position peaked at $9.89M in Q4 2013.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Gateway Investment Advisers's 13F filing for Q1 2015, filed 21 Apr 2015.